HCW Biologics Terminates Agreement
HCW Biologics terminates material definitive agreement, files 8-K with SEC. Financial statements and exhibits included.
Filed: 2026-05-27 AccNo: 0001493152-26-025336 Size: 239 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits